Cargando…
The value of hybrid interstitial tandem and ring applicators for organ at risk dose reduction in small volume cervical cancer
PURPOSE: Magnetic resonance imaging (MRI)-guided adaptive brachytherapy is the standard of care for cervical cancer. Hybrid intracavitary/interstitial applicators for bulky tumor (high-risk clinical target volume [HR-CTV] > 30 cc) dose escalation is recommended in the EMBRACE II trial. The value...
Autores principales: | Crossley, Najeeb, Tipton, Camrin, Meier, Teresa, Sudhoff, Mickaela, Kharofa, Jordan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073346/ https://www.ncbi.nlm.nih.gov/pubmed/32190065 http://dx.doi.org/10.5114/jcb.2020.93515 |
Ejemplares similares
-
Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation
por: Nelson, Bailey, et al.
Publicado: (2022) -
Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes
por: Rivera, Amanda, et al.
Publicado: (2021) -
A comparison of tandem ring and tandem ovoid treatment as a curative brachytherapy component for cervical cancer
por: Gursel, Sukriye Bilge, et al.
Publicado: (2020) -
Application of the patient-reported outcomes continual reassessment method to a phase I study of radiotherapy in endometrial cancer
por: Wages, Nolan A., et al.
Publicado: (2022) -
Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators
por: Moghani, Mona Malekzadeh, et al.
Publicado: (2022)